Conduit Pharmaceuticals Fails Listing Rule
Ticker: CDTTW · Form: 8-K · Filed: May 31, 2024 · CIK: 1896212
| Field | Detail |
|---|---|
| Company | Conduit Pharmaceuticals Inc. (CDTTW) |
| Form Type | 8-K |
| Filed Date | May 31, 2024 |
| Risk Level | high |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001, $11.50 |
| Sentiment | bearish |
Sentiment: bearish
Topics: delisting, listing-standards
TL;DR
Conduit Pharma got a notice they're not meeting listing rules - could get booted!
AI Summary
Conduit Pharmaceuticals Inc. received a notice on May 28, 2024, indicating it failed to meet a continued listing rule or standard for its securities. The company, formerly known as Murphy Canyon Acquisition Corp., is incorporated in Delaware and headquartered in San Diego, CA.
Why It Matters
Failure to meet listing standards can lead to delisting from an exchange, significantly impacting liquidity and investor confidence.
Risk Assessment
Risk Level: high — Failure to meet listing standards is a serious issue that could lead to delisting.
Key Players & Entities
- Conduit Pharmaceuticals Inc. (company) — Registrant
- Murphy Canyon Acquisition Corp. (company) — Former company name
- May 28, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- San Diego, CA (location) — Business address city and state
FAQ
What specific listing rule did Conduit Pharmaceuticals Inc. fail to meet?
The filing states that the company received a notice of 'Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard' but does not specify the exact rule violated.
What is the date of the earliest event reported in this 8-K filing?
The date of the earliest event reported is May 28, 2024.
What was Conduit Pharmaceuticals Inc. formerly known as?
Conduit Pharmaceuticals Inc. was formerly known as Murphy Canyon Acquisition Corp.
In which state is Conduit Pharmaceuticals Inc. incorporated?
Conduit Pharmaceuticals Inc. is incorporated in Delaware.
What is the business address of Conduit Pharmaceuticals Inc.?
The business address is 4995 Murphy Canyon Road, Suite 300, San Diego, CA 92123.
Filing Stats: 598 words · 2 min read · ~2 pages · Grade level 11.8 · Accepted 2024-05-31 17:00:36
Key Financial Figures
- $0.0001 — nge on which registered Common Stock, $0.0001 par value per share CDT The Nasdaq
- $11.50 — of Common Stock at an exercise price of $11.50 CDTTW The Nasdaq Stock Market LLC
Filing Documents
- form8-k.htm (8-K) — 40KB
- 0001493152-24-022228.txt ( ) — 257KB
- cdt-20240528.xsd (EX-101.SCH) — 4KB
- cdt-20240528_def.xml (EX-101.DEF) — 26KB
- cdt-20240528_lab.xml (EX-101.LAB) — 36KB
- cdt-20240528_pre.xml (EX-101.PRE) — 25KB
- form8-k_htm.xml (XML) — 6KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: May 31, 2024 CONDUIT PHARMACEUTICALS INC. By: /s/ Dr. David Tapolczay Name: Dr. David Tapolczay Title: Chief Executive Officer